382 related articles for article (PubMed ID: 15946758)
1. Blends of aqueous polymer dispersions used for pellet coating: importance of the particle size.
Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2005 Jul; 105(3):226-39. PubMed ID: 15946758
[TBL] [Abstract][Full Text] [Related]
2. Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2003 May; 89(3):457-71. PubMed ID: 12737848
[TBL] [Abstract][Full Text] [Related]
3. Aqueous HPMCAS coatings: effects of formulation and processing parameters on drug release and mass transport mechanisms.
Siepmann F; Siepmann J; Walther M; MacRae R; Bodmeier R
Eur J Pharm Biopharm; 2006 Jul; 63(3):262-9. PubMed ID: 16621484
[TBL] [Abstract][Full Text] [Related]
4. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176
[TBL] [Abstract][Full Text] [Related]
5. Influence of aqueous coatings on the stability of enteric coated pellets and tablets.
Thoma K; Bechtold K
Eur J Pharm Biopharm; 1999 Jan; 47(1):39-50. PubMed ID: 10234526
[TBL] [Abstract][Full Text] [Related]
6. Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
Pharm Res; 2004 May; 21(5):882-90. PubMed ID: 15180349
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers.
Kranz H; Gutsche S
Int J Pharm; 2009 Oct; 380(1-2):112-9. PubMed ID: 19632313
[TBL] [Abstract][Full Text] [Related]
8. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
Pharm Res; 2005 Jul; 22(7):1129-41. PubMed ID: 16028014
[TBL] [Abstract][Full Text] [Related]
9. Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers.
Kojima M; Nakagami H
J Control Release; 2002 Aug; 82(2-3):335-43. PubMed ID: 12175747
[TBL] [Abstract][Full Text] [Related]
10. Properties of free films prepared from aqueous polymers by a spraying technique.
Obara S; McGinity JW
Pharm Res; 1994 Nov; 11(11):1562-7. PubMed ID: 7870672
[TBL] [Abstract][Full Text] [Related]
11. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
12. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
Wulff R; Leopold CS
Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
[TBL] [Abstract][Full Text] [Related]
13. pH-sensitive polymer blends used as coating materials to control drug release from spherical beads: importance of the type of core.
Lecomte F; Siepmann J; Walther M; Macrae RJ; Bodmeier R
Biomacromolecules; 2005; 6(4):2074-83. PubMed ID: 16004447
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
[TBL] [Abstract][Full Text] [Related]
15. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
16. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
17. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.
Fang Y; Wang G; Zhang R; Liu Z; Liu Z; Wu X; Cao D
AAPS PharmSciTech; 2014 Jun; 15(3):513-21. PubMed ID: 24590548
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
19. Pairwise polymer blends for oral drug delivery.
Marks JA; Wegiel LA; Taylor LS; Edgar KJ
J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
[TBL] [Abstract][Full Text] [Related]
20. Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability.
Chen K; Chang HHR; Shalviri A; Li J; Lugtu-Pe JA; Kane A; Wu XY
Eur J Pharm Biopharm; 2017 Nov; 120():116-125. PubMed ID: 28887098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
